Low Cell Numbers
1-100 cells per experiment - suitable for primary, iPS or other rare cell types
Various sublibraries from ICCB and FDA approved chemical compounds can be screened on the DMA
Easily adaptable to different nano liquid dispensers to perform powerful cell screenings
THE DROPLET MICROARRAY (DMA) TECHNOLOGY:
The Droplet Microarray (DMA) is Aquarray’s patented technology for cell cultivation, high throughput screening (HTS) and biochemical assay platforms. The DMA
delivers the potential of microarray technologies to the field of cell based screening systems. Aquarray opens multiplexing opportunities to research areas all the way from basic research over industrial HTS to clinical applications.
+49 7247 206 90 08
Aquarray Drug Discovery
In a freshly developed approach, Aquarray combines the main components of Drug Discovery on a single platform.
Within days a unique library of new compounds can be synthesized, analyzed, and tested in a primary screening on cells on a single DMA slide.
THE AQUARRAY TEAM
Dr. Wolfgang Sipos
Prof. Dr. Dr. Gunter Festel
Prof. Dr. Pavel Levkin
Dr. Anna Popova
Dr. Alexandra Matzke-Ogi
Dr. Maximilian Benz
Prof. Dr. Jörg Vienken
Prof. Dr. Michael Grunze